Advertisement

Index by author

November 01, 1979; Volume 7,Issue 6

A

  1. Aldridge, A

    1. The effects of phenobarbital and beta-naphthoflavone on the elimination kinetics and metabolite pattern of caffeine in the beagle dog.
      A Aldridge and A H Neims
      Drug Metabolism and Disposition November 1979, 7 (6) 378-382;

  2. Alvinerie, M

    1. The pharmacokinetic profile of ochratoxin A in the rat after oral and intravenous administration.
      P Galtier, J L Charpenteau, M Alvinerie and C Labouche
      Drug Metabolism and Disposition November 1979, 7 (6) 429-434;

  3. Anderson, M W

    1. Studies on the persistence of basic amines in the rabbit lung.
      A G Wilson, R D Pickett, T E Eling and M W Anderson
      Drug Metabolism and Disposition November 1979, 7 (6) 420-424;

  4. Andersson, B

    1. Regulation of glucuronidation and sulfate conjugation in isolated hepatocytes.
      P Moldéus, B Andersson and V Gergely
      Drug Metabolism and Disposition November 1979, 7 (6) 416-419;

  5. Andresen, B D

    1. Metabolism of acebutolol-d6 in the rat correlates with the identification of a new metabolite in human urine.
      B D Andresen and F T Davis
      Drug Metabolism and Disposition November 1979, 7 (6) 360-365;

  6. Arakawa, S

    1. Metabolism of a new analgesic agent, dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl]ethanol dihydrochloride, in rats.
      M Hashimoto, Y Sekine, J Muto, T Yamaguchi, T Maeda, Y Utsui, K Yoshida, S Arakawa, N Shimokawa and K Shimakawa
      Drug Metabolism and Disposition November 1979, 7 (6) 435-441;

B

  1. Benet, L Z

    1. Comparative bioavailability and pharmacokinetic studies of azathioprine and 6-mercaptopurine in the rhesus monkey.
      T L Ding and L Z Benet
      Drug Metabolism and Disposition November 1979, 7 (6) 373-377;

  2. Bolton, G C

    1. The metabolic disposition of [14C]pivhydrazine, [14C]mebanazine, and [14C]benzylhydrazine in the rat.
      G C Bolton and L A Griffiths
      Drug Metabolism and Disposition November 1979, 7 (6) 388-392;

  3. Bopp, R J

    1. Stereoselective inversion of (R)-(-)-benoxaprofen to the (S)-(+)-enantiomer in humans.
      R J Bopp, J F Nash, A S Ridolfo and E R Shepard
      Drug Metabolism and Disposition November 1979, 7 (6) 356-359;

  4. Breyer-Pfaff, U

    1. Formation of the sulfone metabolite of didesmethylchlorpromazine in the rat in vivo and in vitro.
      H Kreft and U Breyer-Pfaff
      Drug Metabolism and Disposition November 1979, 7 (6) 404-410;

C

  1. Charpenteau, J L

    1. The pharmacokinetic profile of ochratoxin A in the rat after oral and intravenous administration.
      P Galtier, J L Charpenteau, M Alvinerie and C Labouche
      Drug Metabolism and Disposition November 1979, 7 (6) 429-434;

  2. Cresswell, P R

    1. The excretion and metabolism of metiamide in the rat, dog, and man.
      D C Taylor, P R Cresswell and E S Pepper
      Drug Metabolism and Disposition November 1979, 7 (6) 393-398;

D

  1. Davis, F T

    1. Metabolism of acebutolol-d6 in the rat correlates with the identification of a new metabolite in human urine.
      B D Andresen and F T Davis
      Drug Metabolism and Disposition November 1979, 7 (6) 360-365;

  2. Davis, M E

    1. Absence of metabolism of morphine during accumulation by isolated perfused rabbit lung.
      M E Davis and H M Mehendale
      Drug Metabolism and Disposition November 1979, 7 (6) 425-428;

  3. Denson, D D

    1. Isotopic probe of the mechanism of methoxyflurane defluorination.
      B A Hitt, R I Mazze and D D Denson
      Drug Metabolism and Disposition November 1979, 7 (6) 446-447;

  4. Ding, T L

    1. Comparative bioavailability and pharmacokinetic studies of azathioprine and 6-mercaptopurine in the rhesus monkey.
      T L Ding and L Z Benet
      Drug Metabolism and Disposition November 1979, 7 (6) 373-377;

E

  1. Eling, T E

    1. Studies on the persistence of basic amines in the rabbit lung.
      A G Wilson, R D Pickett, T E Eling and M W Anderson
      Drug Metabolism and Disposition November 1979, 7 (6) 420-424;

G

  1. Galtier, P

    1. The pharmacokinetic profile of ochratoxin A in the rat after oral and intravenous administration.
      P Galtier, J L Charpenteau, M Alvinerie and C Labouche
      Drug Metabolism and Disposition November 1979, 7 (6) 429-434;

  2. Gergely, V

    1. Regulation of glucuronidation and sulfate conjugation in isolated hepatocytes.
      P Moldéus, B Andersson and V Gergely
      Drug Metabolism and Disposition November 1979, 7 (6) 416-419;

  3. Gillette, J R

    1. A method for the estimation of the fraction of a precursor that is converted to a metabolite in rat in vivo with phenacetin and acetaminophen.
      K S Pang, K Strobl and J R Gillette
      Drug Metabolism and Disposition November 1979, 7 (6) 366-372;

  4. Griffiths, L A

    1. The metabolic disposition of [14C]pivhydrazine, [14C]mebanazine, and [14C]benzylhydrazine in the rat.
      G C Bolton and L A Griffiths
      Drug Metabolism and Disposition November 1979, 7 (6) 388-392;

  5. Grindel, J M

    1. Characterization of a new urinary metabolite of penfluridol in the rat, rabbit, dog, and man.
      J M Grindel, B H Migdalof and J F Hills
      Drug Metabolism and Disposition November 1979, 7 (6) 448;

H

  1. Hashimoto, M

    1. Metabolism of a new analgesic agent, dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl]ethanol dihydrochloride, in rats.
      M Hashimoto, Y Sekine, J Muto, T Yamaguchi, T Maeda, Y Utsui, K Yoshida, S Arakawa, N Shimokawa and K Shimakawa
      Drug Metabolism and Disposition November 1979, 7 (6) 435-441;

  2. Hills, J F

    1. Characterization of a new urinary metabolite of penfluridol in the rat, rabbit, dog, and man.
      J M Grindel, B H Migdalof and J F Hills
      Drug Metabolism and Disposition November 1979, 7 (6) 448;

  3. Hitt, B A

    1. Isotopic probe of the mechanism of methoxyflurane defluorination.
      B A Hitt, R I Mazze and D D Denson
      Drug Metabolism and Disposition November 1979, 7 (6) 446-447;

K

  1. Kreft, H

    1. Formation of the sulfone metabolite of didesmethylchlorpromazine in the rat in vivo and in vitro.
      H Kreft and U Breyer-Pfaff
      Drug Metabolism and Disposition November 1979, 7 (6) 404-410;

L

  1. Labouche, C

    1. The pharmacokinetic profile of ochratoxin A in the rat after oral and intravenous administration.
      P Galtier, J L Charpenteau, M Alvinerie and C Labouche
      Drug Metabolism and Disposition November 1979, 7 (6) 429-434;

M

  1. Maeda, T

    1. Metabolism of a new analgesic agent, dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl]ethanol dihydrochloride, in rats.
      M Hashimoto, Y Sekine, J Muto, T Yamaguchi, T Maeda, Y Utsui, K Yoshida, S Arakawa, N Shimokawa and K Shimakawa
      Drug Metabolism and Disposition November 1979, 7 (6) 435-441;

  2. Mazze, R I

    1. Isotopic probe of the mechanism of methoxyflurane defluorination.
      B A Hitt, R I Mazze and D D Denson
      Drug Metabolism and Disposition November 1979, 7 (6) 446-447;

  3. Mehendale, H M

    1. Absence of metabolism of morphine during accumulation by isolated perfused rabbit lung.
      M E Davis and H M Mehendale
      Drug Metabolism and Disposition November 1979, 7 (6) 425-428;
    2. Uptake and accumulation of chlorpromazine in the isolated perfused rabbit lung.
      Y Ohmiya and H M Mehendale
      Drug Metabolism and Disposition November 1979, 7 (6) 442-443;

  4. Migdalof, B H

    1. Characterization of a new urinary metabolite of penfluridol in the rat, rabbit, dog, and man.
      J M Grindel, B H Migdalof and J F Hills
      Drug Metabolism and Disposition November 1979, 7 (6) 448;

  5. Mitchell, S C

    1. Metabolism of phenothiazine in the guinea pig.
      S C Mitchell and R H Waring
      Drug Metabolism and Disposition November 1979, 7 (6) 399-403;

  6. Moldéus, P

    1. Regulation of glucuronidation and sulfate conjugation in isolated hepatocytes.
      P Moldéus, B Andersson and V Gergely
      Drug Metabolism and Disposition November 1979, 7 (6) 416-419;

  7. Muto, J

    1. Metabolism of a new analgesic agent, dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl]ethanol dihydrochloride, in rats.
      M Hashimoto, Y Sekine, J Muto, T Yamaguchi, T Maeda, Y Utsui, K Yoshida, S Arakawa, N Shimokawa and K Shimakawa
      Drug Metabolism and Disposition November 1979, 7 (6) 435-441;

N

  1. Nash, J F

    1. Stereoselective inversion of (R)-(-)-benoxaprofen to the (S)-(+)-enantiomer in humans.
      R J Bopp, J F Nash, A S Ridolfo and E R Shepard
      Drug Metabolism and Disposition November 1979, 7 (6) 356-359;

  2. Neims, A H

    1. The effects of phenobarbital and beta-naphthoflavone on the elimination kinetics and metabolite pattern of caffeine in the beagle dog.
      A Aldridge and A H Neims
      Drug Metabolism and Disposition November 1979, 7 (6) 378-382;

  3. Nelson, W L

    1. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of propranolol to 4'-hydroxypropranolol in the rat and in man.
      W L Nelson and M L Powell
      Drug Metabolism and Disposition November 1979, 7 (6) 351-355;

O

  1. Ogilvie, R I

    1. Biotransformation of furosemide in patients with acute pulmonary edema.
      J Perez, D S Sitar and R I Ogilvie
      Drug Metabolism and Disposition November 1979, 7 (6) 383-387;

  2. Ohmiya, Y

    1. Uptake and accumulation of chlorpromazine in the isolated perfused rabbit lung.
      Y Ohmiya and H M Mehendale
      Drug Metabolism and Disposition November 1979, 7 (6) 442-443;

P

  1. Pang, K S

    1. A method for the estimation of the fraction of a precursor that is converted to a metabolite in rat in vivo with phenacetin and acetaminophen.
      K S Pang, K Strobl and J R Gillette
      Drug Metabolism and Disposition November 1979, 7 (6) 366-372;

  2. Pepper, E S

    1. The excretion and metabolism of metiamide in the rat, dog, and man.
      D C Taylor, P R Cresswell and E S Pepper
      Drug Metabolism and Disposition November 1979, 7 (6) 393-398;

  3. Perez, J

    1. Biotransformation of furosemide in patients with acute pulmonary edema.
      J Perez, D S Sitar and R I Ogilvie
      Drug Metabolism and Disposition November 1979, 7 (6) 383-387;

  4. Pickett, R D

    1. Studies on the persistence of basic amines in the rabbit lung.
      A G Wilson, R D Pickett, T E Eling and M W Anderson
      Drug Metabolism and Disposition November 1979, 7 (6) 420-424;

  5. Powell, M L

    1. Evidence for an arene oxide-NIH shift pathway in the metabolic conversion of propranolol to 4'-hydroxypropranolol in the rat and in man.
      W L Nelson and M L Powell
      Drug Metabolism and Disposition November 1979, 7 (6) 351-355;

R

  1. Ridolfo, A S

    1. Stereoselective inversion of (R)-(-)-benoxaprofen to the (S)-(+)-enantiomer in humans.
      R J Bopp, J F Nash, A S Ridolfo and E R Shepard
      Drug Metabolism and Disposition November 1979, 7 (6) 356-359;

S

  1. Sekine, Y

    1. Metabolism of a new analgesic agent, dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl]ethanol dihydrochloride, in rats.
      M Hashimoto, Y Sekine, J Muto, T Yamaguchi, T Maeda, Y Utsui, K Yoshida, S Arakawa, N Shimokawa and K Shimakawa
      Drug Metabolism and Disposition November 1979, 7 (6) 435-441;

  2. Shapiro, B H

    1. Hepatic drug metabolism in pseudohermaphroditic rats.
      B R Sonawane, S J Yaffe and B H Shapiro
      Drug Metabolism and Disposition November 1979, 7 (6) 444-445;

  3. Shepard, E R

    1. Stereoselective inversion of (R)-(-)-benoxaprofen to the (S)-(+)-enantiomer in humans.
      R J Bopp, J F Nash, A S Ridolfo and E R Shepard
      Drug Metabolism and Disposition November 1979, 7 (6) 356-359;

  4. Shimakawa, K

    1. Metabolism of a new analgesic agent, dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl]ethanol dihydrochloride, in rats.
      M Hashimoto, Y Sekine, J Muto, T Yamaguchi, T Maeda, Y Utsui, K Yoshida, S Arakawa, N Shimokawa and K Shimakawa
      Drug Metabolism and Disposition November 1979, 7 (6) 435-441;

  5. Shimokawa, N

    1. Metabolism of a new analgesic agent, dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl]ethanol dihydrochloride, in rats.
      M Hashimoto, Y Sekine, J Muto, T Yamaguchi, T Maeda, Y Utsui, K Yoshida, S Arakawa, N Shimokawa and K Shimakawa
      Drug Metabolism and Disposition November 1979, 7 (6) 435-441;

  6. Sitar, D S

    1. Biotransformation of furosemide in patients with acute pulmonary edema.
      J Perez, D S Sitar and R I Ogilvie
      Drug Metabolism and Disposition November 1979, 7 (6) 383-387;

  7. Sonawane, B R

    1. Hepatic drug metabolism in pseudohermaphroditic rats.
      B R Sonawane, S J Yaffe and B H Shapiro
      Drug Metabolism and Disposition November 1979, 7 (6) 444-445;

  8. Strobl, K

    1. A method for the estimation of the fraction of a precursor that is converted to a metabolite in rat in vivo with phenacetin and acetaminophen.
      K S Pang, K Strobl and J R Gillette
      Drug Metabolism and Disposition November 1979, 7 (6) 366-372;

T

  1. Taylor, D C

    1. The excretion and metabolism of metiamide in the rat, dog, and man.
      D C Taylor, P R Cresswell and E S Pepper
      Drug Metabolism and Disposition November 1979, 7 (6) 393-398;

  2. Thithapandha, A

    1. The effects of cyproheptadine hydroxhloride on hepatic drug-metabolizing enzymes in the rat.
      S Unchern and A Thithapandha
      Drug Metabolism and Disposition November 1979, 7 (6) 411-415;

  3. Thonnart, N

    1. In vitro metabolism of clocoumarol, a new 4-hydroxycoumarin anticoagulant; identification of two additional metabolites.
      N Thonnart, M Vanhaelen and R Vanhaelen-Fastré
      Drug Metabolism and Disposition November 1979, 7 (6) 449-450;

U

  1. Unchern, S

    1. The effects of cyproheptadine hydroxhloride on hepatic drug-metabolizing enzymes in the rat.
      S Unchern and A Thithapandha
      Drug Metabolism and Disposition November 1979, 7 (6) 411-415;

  2. Utsui, Y

    1. Metabolism of a new analgesic agent, dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl]ethanol dihydrochloride, in rats.
      M Hashimoto, Y Sekine, J Muto, T Yamaguchi, T Maeda, Y Utsui, K Yoshida, S Arakawa, N Shimokawa and K Shimakawa
      Drug Metabolism and Disposition November 1979, 7 (6) 435-441;

V

  1. Vanhaelen, M

    1. In vitro metabolism of clocoumarol, a new 4-hydroxycoumarin anticoagulant; identification of two additional metabolites.
      N Thonnart, M Vanhaelen and R Vanhaelen-Fastré
      Drug Metabolism and Disposition November 1979, 7 (6) 449-450;

  2. Vanhaelen-Fastré, R

    1. In vitro metabolism of clocoumarol, a new 4-hydroxycoumarin anticoagulant; identification of two additional metabolites.
      N Thonnart, M Vanhaelen and R Vanhaelen-Fastré
      Drug Metabolism and Disposition November 1979, 7 (6) 449-450;

W

  1. Waring, R H

    1. Metabolism of phenothiazine in the guinea pig.
      S C Mitchell and R H Waring
      Drug Metabolism and Disposition November 1979, 7 (6) 399-403;

  2. Wilson, A G

    1. Studies on the persistence of basic amines in the rabbit lung.
      A G Wilson, R D Pickett, T E Eling and M W Anderson
      Drug Metabolism and Disposition November 1979, 7 (6) 420-424;

Y

  1. Yaffe, S J

    1. Hepatic drug metabolism in pseudohermaphroditic rats.
      B R Sonawane, S J Yaffe and B H Shapiro
      Drug Metabolism and Disposition November 1979, 7 (6) 444-445;

  2. Yamaguchi, T

    1. Metabolism of a new analgesic agent, dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl]ethanol dihydrochloride, in rats.
      M Hashimoto, Y Sekine, J Muto, T Yamaguchi, T Maeda, Y Utsui, K Yoshida, S Arakawa, N Shimokawa and K Shimakawa
      Drug Metabolism and Disposition November 1979, 7 (6) 435-441;

  3. Yoshida, K

    1. Metabolism of a new analgesic agent, dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl]ethanol dihydrochloride, in rats.
      M Hashimoto, Y Sekine, J Muto, T Yamaguchi, T Maeda, Y Utsui, K Yoshida, S Arakawa, N Shimokawa and K Shimakawa
      Drug Metabolism and Disposition November 1979, 7 (6) 435-441;
Back to top

In this issue